XML 50 R27.htm IDEA: XBRL DOCUMENT
v3.20.1

Condensed Consolidating Financial Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2020
Condensed Financial Information Disclosure [Abstract] |
Condensed Consolidating Statement of Income |
| Three Months Ended March 31, 2020
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 4.6 |  |  | $ | 622.5 |  |  | $ | 323.3 |  |  | $ | 266.8 |  |  | $ | (35.2 | ) |  | $ | 1,182.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 16.7 |  |  | 309.8 |  |  | 164.2 |  |  | 193.3 |  |  | (4.9 | ) |  | 679.1 |
Other operating expenses | 9.6 |  |  | 86.9 |  |  | 52.0 |  |  | 24.1 |  |  | (13.0 | ) |  | 159.6 |
Occupancy costs | 0.6 |  |  | 25.4 |  |  | 6.7 |  |  | 4.8 |  |  | (17.3 | ) |  | 20.2 |
Supplies | — |  |  | 26.5 |  |  | 13.2 |  |  | 6.0 |  |  | — |  |  | 45.7 |
General and administrative expenses | 34.7 |  |  | — |  |  | — |  |  | 0.9 |  |  | — |  |  | 35.6 |
Depreciation and amortization | 5.3 |  |  | 28.7 |  |  | 15.0 |  |  | 9.8 |  |  | — |  |  | 58.8 |
Government, class action, and related settlements | 2.8 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2.8 |
Total operating expenses | 69.7 |  |  | 477.3 |  |  | 251.1 |  |  | 238.9 |  |  | (35.2 | ) |  | 1,001.8 |
Interest expense and amortization of debt discounts and fees | 35.8 |  |  | 6.3 |  |  | 1.4 |  |  | 4.9 |  |  | (5.2 | ) |  | 43.2 |
Other (income) expense | (2.3 | ) |  | (0.4 | ) |  | 1.6 |  |  | (2.2 | ) |  | 5.2 |  |  | 1.9 |
Equity in net income of nonconsolidated affiliates | — |  |  | (0.5 | ) |  | (0.1 | ) |  | (0.2 | ) |  | — |  |  | (0.8 | )
Equity in net income of consolidated affiliates | (122.2 | ) |  | (17.8 | ) |  | — |  |  | — |  |  | 140.0 |  |  | — |
Management fees | (42.0 | ) |  | 30.2 |  |  | 11.8 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 65.6 |  |  | 127.4 |  |  | 57.5 |  |  | 25.4 |  |  | (140.0 | ) |  | 135.9 |
Provision for income tax (benefit) expense | (21.5 | ) |  | 33.0 |  |  | 9.1 |  |  | 6.5 |  |  | — |  |  | 27.1 |
Income from continuing operations | 87.1 |  |  | 94.4 |  |  | 48.4 |  |  | 18.9 |  |  | (140.0 | ) |  | 108.8 |
Loss from discontinued operations, net of tax | (0.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.1 | )
Net and comprehensive income | 87.0 |  |  | 94.4 |  |  | 48.4 |  |  | 18.9 |  |  | (140.0 | ) |  | 108.7 |
Less: Net and comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (21.2 | ) |  | (0.5 | ) |  | — |  |  | (21.7 | )
Net and comprehensive income attributable to Encompass Health | $ | 87.0 |  |  | $ | 94.4 |  |  | $ | 27.2 |  |  | $ | 18.4 |  |  | $ | (140.0 | ) |  | $ | 87.0 |
| Three Months Ended March 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.1 |  |  | $ | 606.5 |  |  | $ | 296.5 |  |  | $ | 249.5 |  |  | $ | (33.6 | ) |  | $ | 1,124.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 15.9 |  |  | 288.9 |  |  | 148.0 |  |  | 173.1 |  |  | (5.1 | ) |  | 620.8 |
Other operating expenses | 10.3 |  |  | 84.7 |  |  | 46.8 |  |  | 20.8 |  |  | (12.5 | ) |  | 150.1 |
Occupancy costs | 0.5 |  |  | 24.9 |  |  | 6.5 |  |  | 3.7 |  |  | (16.0 | ) |  | 19.6 |
Supplies | — |  |  | 24.0 |  |  | 11.6 |  |  | 4.5 |  |  | — |  |  | 40.1 |
General and administrative expenses | 39.9 |  |  | — |  |  | — |  |  | 13.5 |  |  | — |  |  | 53.4 |
Depreciation and amortization | 5.0 |  |  | 26.3 |  |  | 13.1 |  |  | 8.1 |  |  | — |  |  | 52.5 |
Total operating expenses | 71.6 |  |  | 448.8 |  |  | 226.0 |  |  | 223.7 |  |  | (33.6 | ) |  | 936.5 |
Interest expense and amortization of debt discounts and fees | 30.1 |  |  | 6.2 |  |  | 1.3 |  |  | 6.4 |  |  | (6.8 | ) |  | 37.2 |
Other income | (7.7 | ) |  | (0.3 | ) |  | (2.5 | ) |  | — |  |  | 6.8 |  |  | (3.7 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (2.0 | ) |  | (0.1 | ) |  | (0.4 | ) |  | — |  |  | (2.5 | )
Equity in net income of consolidated affiliates | (130.2 | ) |  | (17.1 | ) |  | — |  |  | — |  |  | 147.3 |  |  | — |
Management fees | (39.8 | ) |  | 29.5 |  |  | 10.3 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 81.1 |  |  | 141.4 |  |  | 61.5 |  |  | 19.8 |  |  | (147.3 | ) |  | 156.5 |
Provision for income tax (benefit) expense | (21.7 | ) |  | 37.8 |  |  | 10.2 |  |  | 4.5 |  |  | — |  |  | 30.8 |
Income from continuing operations | 102.8 |  |  | 103.6 |  |  | 51.3 |  |  | 15.3 |  |  | (147.3 | ) |  | 125.7 |
Loss from discontinued operations, net of tax | (0.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.5 | )
Net and comprehensive income | 102.3 |  |  | 103.6 |  |  | 51.3 |  |  | 15.3 |  |  | (147.3 | ) |  | 125.2 |
Less: Net and comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (21.2 | ) |  | (1.7 | ) |  | — |  |  | (22.9 | )
Net and comprehensive income attributable to Encompass Health | $ | 102.3 |  |  | $ | 103.6 |  |  | $ | 30.1 |  |  | $ | 13.6 |  |  | $ | (147.3 | ) |  | $ | 102.3 |
Condensed Consolidating Statement of Comprehensive Income |
| Three Months Ended March 31, 2020
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 4.6 |  |  | $ | 622.5 |  |  | $ | 323.3 |  |  | $ | 266.8 |  |  | $ | (35.2 | ) |  | $ | 1,182.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 16.7 |  |  | 309.8 |  |  | 164.2 |  |  | 193.3 |  |  | (4.9 | ) |  | 679.1 |
Other operating expenses | 9.6 |  |  | 86.9 |  |  | 52.0 |  |  | 24.1 |  |  | (13.0 | ) |  | 159.6 |
Occupancy costs | 0.6 |  |  | 25.4 |  |  | 6.7 |  |  | 4.8 |  |  | (17.3 | ) |  | 20.2 |
Supplies | — |  |  | 26.5 |  |  | 13.2 |  |  | 6.0 |  |  | — |  |  | 45.7 |
General and administrative expenses | 34.7 |  |  | — |  |  | — |  |  | 0.9 |  |  | — |  |  | 35.6 |
Depreciation and amortization | 5.3 |  |  | 28.7 |  |  | 15.0 |  |  | 9.8 |  |  | — |  |  | 58.8 |
Government, class action, and related settlements | 2.8 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2.8 |
Total operating expenses | 69.7 |  |  | 477.3 |  |  | 251.1 |  |  | 238.9 |  |  | (35.2 | ) |  | 1,001.8 |
Interest expense and amortization of debt discounts and fees | 35.8 |  |  | 6.3 |  |  | 1.4 |  |  | 4.9 |  |  | (5.2 | ) |  | 43.2 |
Other (income) expense | (2.3 | ) |  | (0.4 | ) |  | 1.6 |  |  | (2.2 | ) |  | 5.2 |  |  | 1.9 |
Equity in net income of nonconsolidated affiliates | — |  |  | (0.5 | ) |  | (0.1 | ) |  | (0.2 | ) |  | — |  |  | (0.8 | )
Equity in net income of consolidated affiliates | (122.2 | ) |  | (17.8 | ) |  | — |  |  | — |  |  | 140.0 |  |  | — |
Management fees | (42.0 | ) |  | 30.2 |  |  | 11.8 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 65.6 |  |  | 127.4 |  |  | 57.5 |  |  | 25.4 |  |  | (140.0 | ) |  | 135.9 |
Provision for income tax (benefit) expense | (21.5 | ) |  | 33.0 |  |  | 9.1 |  |  | 6.5 |  |  | — |  |  | 27.1 |
Income from continuing operations | 87.1 |  |  | 94.4 |  |  | 48.4 |  |  | 18.9 |  |  | (140.0 | ) |  | 108.8 |
Loss from discontinued operations, net of tax | (0.1 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.1 | )
Net and comprehensive income | 87.0 |  |  | 94.4 |  |  | 48.4 |  |  | 18.9 |  |  | (140.0 | ) |  | 108.7 |
Less: Net and comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (21.2 | ) |  | (0.5 | ) |  | — |  |  | (21.7 | )
Net and comprehensive income attributable to Encompass Health | $ | 87.0 |  |  | $ | 94.4 |  |  | $ | 27.2 |  |  | $ | 18.4 |  |  | $ | (140.0 | ) |  | $ | 87.0 |
| Three Months Ended March 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.1 |  |  | $ | 606.5 |  |  | $ | 296.5 |  |  | $ | 249.5 |  |  | $ | (33.6 | ) |  | $ | 1,124.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 15.9 |  |  | 288.9 |  |  | 148.0 |  |  | 173.1 |  |  | (5.1 | ) |  | 620.8 |
Other operating expenses | 10.3 |  |  | 84.7 |  |  | 46.8 |  |  | 20.8 |  |  | (12.5 | ) |  | 150.1 |
Occupancy costs | 0.5 |  |  | 24.9 |  |  | 6.5 |  |  | 3.7 |  |  | (16.0 | ) |  | 19.6 |
Supplies | — |  |  | 24.0 |  |  | 11.6 |  |  | 4.5 |  |  | — |  |  | 40.1 |
General and administrative expenses | 39.9 |  |  | — |  |  | — |  |  | 13.5 |  |  | — |  |  | 53.4 |
Depreciation and amortization | 5.0 |  |  | 26.3 |  |  | 13.1 |  |  | 8.1 |  |  | — |  |  | 52.5 |
Total operating expenses | 71.6 |  |  | 448.8 |  |  | 226.0 |  |  | 223.7 |  |  | (33.6 | ) |  | 936.5 |
Interest expense and amortization of debt discounts and fees | 30.1 |  |  | 6.2 |  |  | 1.3 |  |  | 6.4 |  |  | (6.8 | ) |  | 37.2 |
Other income | (7.7 | ) |  | (0.3 | ) |  | (2.5 | ) |  | — |  |  | 6.8 |  |  | (3.7 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (2.0 | ) |  | (0.1 | ) |  | (0.4 | ) |  | — |  |  | (2.5 | )
Equity in net income of consolidated affiliates | (130.2 | ) |  | (17.1 | ) |  | — |  |  | — |  |  | 147.3 |  |  | — |
Management fees | (39.8 | ) |  | 29.5 |  |  | 10.3 |  |  | — |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 81.1 |  |  | 141.4 |  |  | 61.5 |  |  | 19.8 |  |  | (147.3 | ) |  | 156.5 |
Provision for income tax (benefit) expense | (21.7 | ) |  | 37.8 |  |  | 10.2 |  |  | 4.5 |  |  | — |  |  | 30.8 |
Income from continuing operations | 102.8 |  |  | 103.6 |  |  | 51.3 |  |  | 15.3 |  |  | (147.3 | ) |  | 125.7 |
Loss from discontinued operations, net of tax | (0.5 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (0.5 | )
Net and comprehensive income | 102.3 |  |  | 103.6 |  |  | 51.3 |  |  | 15.3 |  |  | (147.3 | ) |  | 125.2 |
Less: Net and comprehensive income attributable to noncontrolling interests | — |  |  | — |  |  | (21.2 | ) |  | (1.7 | ) |  | — |  |  | (22.9 | )
Net and comprehensive income attributable to Encompass Health | $ | 102.3 |  |  | $ | 103.6 |  |  | $ | 30.1 |  |  | $ | 13.6 |  |  | $ | (147.3 | ) |  | $ | 102.3 |
Condensed Consolidating Balance Sheet |
| As of March 31, 2020
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 79.0 |  |  | $ | 3.7 |  |  | $ | 7.8 |  |  | $ | 14.4 |  |  | $ | — |  |  | $ | 104.9 |
Restricted cash | — |  |  | — |  |  | 56.7 |  |  | — |  |  | — |  |  | 56.7 |
Accounts receivable | — |  |  | 270.8 |  |  | 131.6 |  |  | 141.0 |  |  | — |  |  | 543.4 |
Other current assets | 79.8 |  |  | 34.7 |  |  | 45.1 |  |  | 7.2 |  |  | (87.3 | ) |  | 79.5 |
Total current assets | 158.8 |  |  | 309.2 |  |  | 241.2 |  |  | 162.6 |  |  | (87.3 | ) |  | 784.5 |
Property and equipment, net | 138.5 |  |  | 1,268.0 |  |  | 567.4 |  |  | 29.4 |  |  | — |  |  | 2,003.3 |
Operating lease right-of-use assets | 9.7 |  |  | 158.0 |  |  | 80.1 |  |  | 43.2 |  |  | (23.1 | ) |  | 267.9 |
Goodwill | — |  |  | 912.2 |  |  | 329.0 |  |  | 1,070.9 |  |  | — |  |  | 2,312.1 |
Intangible assets, net | 15.8 |  |  | 98.9 |  |  | 64.8 |  |  | 285.2 |  |  | — |  |  | 464.7 |
Deferred income tax assets | 52.6 |  |  | 11.1 |  |  | 0.1 |  |  | — |  |  | (62.3 | ) |  | 1.5 |
Other long-term assets | 51.7 |  |  | 86.8 |  |  | 152.9 |  |  | 12.3 |  |  | — |  |  | 303.7 |
Intercompany receivable and investments in consolidated affiliates | 4,245.7 |  |  | 657.6 |  |  | — |  |  | 7.5 |  |  | (4,910.8 | ) |  | — |
Total assets | $ | 4,672.8 |  |  | $ | 3,501.8 |  |  | $ | 1,435.5 |  |  | $ | 1,611.1 |  |  | $ | (5,083.5 | ) |  | $ | 6,137.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 17.0 |  |  | $ | 10.8 |  |  | $ | 3.9 |  |  | $ | 8.5 |  |  | $ | — |  |  | $ | 40.2 |
Current operating lease liabilities | 1.4 |  |  | 19.2 |  |  | 14.2 |  |  | 13.6 |  |  | (7.6 | ) |  | 40.8 |
Accounts payable | 12.5 |  |  | 57.2 |  |  | 25.0 |  |  | 3.3 |  |  | — |  |  | 98.0 |
Accrued expenses and other current liabilities | 171.5 |  |  | 110.4 |  |  | 134.0 |  |  | 78.6 |  |  | (87.3 | ) |  | 407.2 |
Total current liabilities | 202.4 |  |  | 197.6 |  |  | 177.1 |  |  | 104.0 |  |  | (94.9 | ) |  | 586.2 |
Long-term debt, net of current portion | 2,973.0 |  |  | 302.5 |  |  | 40.6 |  |  | 5.8 |  |  | — |  |  | 3,321.9 |
Long-term operating lease liabilities | 8.6 |  |  | 143.5 |  |  | 69.1 |  |  | 29.6 |  |  | (15.7 | ) |  | 235.1 |
Other long-term liabilities | 44.9 |  |  | 12.0 |  |  | 105.0 |  |  | 63.6 |  |  | (62.2 | ) |  | 163.3 |
Intercompany payable | — |  |  | — |  |  | 66.0 |  |  | — |  |  | (66.0 | ) |  | — |
| 3,228.9 |  |  | 655.6 |  |  | 457.8 |  |  | 203.0 |  |  | (238.8 | ) |  | 4,306.5 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 34.0 |  |  | — |  |  | — |  |  | 34.0 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,443.9 |  |  | 2,846.2 |  |  | 590.4 |  |  | 1,408.1 |  |  | (4,844.7 | ) |  | 1,443.9 |
Noncontrolling interests | — |  |  | — |  |  | 353.3 |  |  | — |  |  | — |  |  | 353.3 |
Total shareholders’ equity | 1,443.9 |  |  | 2,846.2 |  |  | 943.7 |  |  | 1,408.1 |  |  | (4,844.7 | ) |  | 1,797.2 |
Total liabilities and shareholders’ equity | $ | 4,672.8 |  |  | $ | 3,501.8 |  |  | $ | 1,435.5 |  |  | $ | 1,611.1 |  |  | $ | (5,083.5 | ) |  | $ | 6,137.7 |
| As of December 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Accounts receivable | — |  |  | 280.4 |  |  | 125.6 |  |  | 100.1 |  |  | — |  |  | 506.1 |
Other current assets | 64.3 |  |  | 35.4 |  |  | 9.3 |  |  | 7.8 |  |  | (19.3 | ) |  | 97.5 |
Total current assets | 118.0 |  |  | 321.0 |  |  | 198.3 |  |  | 137.8 |  |  | (19.3 | ) |  | 755.8 |
Property and equipment, net | 133.4 |  |  | 1,246.0 |  |  | 551.2 |  |  | 28.7 |  |  | — |  |  | 1,959.3 |
Operating lease right-of-use assets | 10.1 |  |  | 171.5 |  |  | 86.5 |  |  | 43.7 |  |  | (35.3 | ) |  | 276.5 |
Goodwill | — |  |  | 912.2 |  |  | 323.0 |  |  | 1,070.0 |  |  | — |  |  | 2,305.2 |
Intangible assets, net | 17.7 |  |  | 101.7 |  |  | 65.3 |  |  | 291.6 |  |  | — |  |  | 476.3 |
Deferred income tax assets | 27.2 |  |  | 11.1 |  |  | 0.1 |  |  | — |  |  | (35.5 | ) |  | 2.9 |
Other long-term assets | 53.6 |  |  | 85.4 |  |  | 151.6 |  |  | 14.1 |  |  | — |  |  | 304.7 |
Intercompany notes receivable | 737.8 |  |  | — |  |  | — |  |  | — |  |  | (737.8 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 3,155.4 |  |  | 523.6 |  |  | — |  |  | — |  |  | (3,679.0 | ) |  | — |
Total assets | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 17.0 |  |  | $ | 10.4 |  |  | $ | 3.8 |  |  | $ | 8.1 |  |  | $ | — |  |  | $ | 39.3 |
Current operating lease liabilities | 1.3 |  |  | 21.9 |  |  | 16.0 |  |  | 12.1 |  |  | (10.9 | ) |  | 40.4 |
Accounts payable | 9.8 |  |  | 56.5 |  |  | 24.3 |  |  | 4.0 |  |  | — |  |  | 94.6 |
Accrued expenses and other current liabilities | 147.4 |  |  | 108.7 |  |  | 109.2 |  |  | 200.7 |  |  | (19.3 | ) |  | 546.7 |
Total current liabilities | 175.5 |  |  | 197.5 |  |  | 153.3 |  |  | 224.9 |  |  | (30.2 | ) |  | 721.0 |
Long-term debt, net of current portion | 2,670.6 |  |  | 305.4 |  |  | 41.6 |  |  | 5.7 |  |  | — |  |  | 3,023.3 |
Long-term operating lease liabilities | 9.0 |  |  | 153.9 |  |  | 73.6 |  |  | 31.9 |  |  | (24.6 | ) |  | 243.8 |
Intercompany notes payable | — |  |  | — |  |  | — |  |  | 737.8 |  |  | (737.8 | ) |  | — |
Other long-term liabilities | 45.9 |  |  | 12.2 |  |  | 100.3 |  |  | 37.0 |  |  | (35.5 | ) |  | 159.9 |
Intercompany payable | — |  |  | — |  |  | 66.0 |  |  | 4.4 |  |  | (70.4 | ) |  | — |
| 2,901.0 |  |  | 669.0 |  |  | 434.8 |  |  | 1,041.7 |  |  | (898.5 | ) |  | 4,148.0 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 31.4 |  |  | 208.2 |  |  | — |  |  | 239.6 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 568.9 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,352.2 |
Noncontrolling interests | — |  |  | — |  |  | 340.9 |  |  | — |  |  | — |  |  | 340.9 |
Total shareholders’ equity | 1,352.2 |  |  | 2,703.5 |  |  | 909.8 |  |  | 336.0 |  |  | (3,608.4 | ) |  | 1,693.1 |
Total liabilities and shareholders’ equity | $ | 4,253.2 |  |  | $ | 3,372.5 |  |  | $ | 1,376.0 |  |  | $ | 1,585.9 |  |  | $ | (4,506.9 | ) |  | $ | 6,080.7 |
Condensed Consolidating Statement of Cash Flows |
| Three Months Ended March 31, 2020
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash (used in) provided by operating activities | $ | (31.2 | ) |  | $ | 117.7 |  |  | $ | 56.8 |  |  | $ | (114.0 | ) |  | $ | — |  |  | $ | 29.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (9.3 | ) |  | (49.5 | ) |  | (23.4 | ) |  | (1.3 | ) |  | — |  |  | (83.5 | )
Acquisitions of businesses, net of cash acquired | — |  |  | — |  |  | — |  |  | (1.1 | ) |  | — |  |  | (1.1 | )
Funding of intercompany note receivable | (15.0 | ) |  | — |  |  | — |  |  | — |  |  | 15.0 |  |  | — |
Other, net | (2.8 | ) |  | 0.7 |  |  | 3.9 |  |  | (0.2 | ) |  | — |  |  | 1.6 |
Net cash used in investing activities | (27.1 | ) |  | (48.8 | ) |  | (19.5 | ) |  | (2.6 | ) |  | 15.0 |  |  | (83.0 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal borrowings on intercompany note payable | — |  |  | — |  |  | — |  |  | 15.0 |  |  | (15.0 | ) |  | — |
Borrowings on revolving credit facility | 330.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 330.0 |
Payments on revolving credit facility | (25.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (25.0 | )
Dividends paid on common stock | (28.9 | ) |  | — |  |  | — |  |  | (0.1 | ) |  | — |  |  | (29.0 | )
Purchase of equity interests in consolidated affiliates | (162.3 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (162.3 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (19.1 | ) |  | — |  |  | — |  |  | (19.1 | )
Taxes paid on behalf of employees for shares withheld | (14.6 | ) |  | — |  |  | — |  |  | (1.0 | ) |  | — |  |  | (15.6 | )
Other, net | (8.5 | ) |  | (2.5 | ) |  | 5.0 |  |  | (1.9 | ) |  | — |  |  | (7.9 | )
Change in intercompany advances | (7.1 | ) |  | (67.9 | ) |  | (14.1 | ) |  | 89.1 |  |  | — |  |  | — |
Net cash provided by (used in) financing activities | 83.6 |  |  | (70.4 | ) |  | (28.2 | ) |  | 101.1 |  |  | (15.0 | ) |  | 71.1 |
Increase (decrease) in cash, cash equivalents, and restricted cash | 25.3 |  |  | (1.5 | ) |  | 9.1 |  |  | (15.5 | ) |  | — |  |  | 17.4 |
Cash, cash equivalents, and restricted cash at beginning of period | 53.7 |  |  | 5.2 |  |  | 70.8 |  |  | 29.9 |  |  | — |  |  | 159.6 |
Cash, cash equivalents, and restricted cash at end of period | $ | 79.0 |  |  | $ | 3.7 |  |  | $ | 79.9 |  |  | $ | 14.4 |  |  | $ | — |  |  | $ | 177.0 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 6.0 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 94.8 |
Restricted cash at beginning of period | — |  |  | — |  |  | 57.4 |  |  | — |  |  | — |  |  | 57.4 |
Restricted cash included in other long term assets at beginning of period | — |  |  | — |  |  | 7.4 |  |  | — |  |  | — |  |  | 7.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 53.7 |  |  | $ | 5.2 |  |  | $ | 70.8 |  |  | $ | 29.9 |  |  | $ | — |  |  | $ | 159.6 |
Cash and cash equivalents at end of period | $ | 79.0 |  |  | $ | 3.7 |  |  | $ | 7.8 |  |  | $ | 14.4 |  |  | $ | — |  |  | $ | 104.9 |
Restricted cash at end of period | — |  |  | — |  |  | 56.7 |  |  | — |  |  | — |  |  | 56.7 |
Restricted cash included in other long-term assets at end of period | — |  |  | — |  |  | 15.4 |  |  | — |  |  | — |  |  | 15.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 79.0 |  |  | $ | 3.7 |  |  | $ | 79.9 |  |  | $ | 14.4 |  |  | $ | — |  |  | $ | 177.0 |
Supplemental schedule of noncash financing activity: |  |  |  |  |  |  |  |  |  |  |
Capital contribution of intercompany note | $ | 853.0 |  |  | $ | — |  |  | $ | — |  |  | (853.0 | ) |  | $ | — |  |  | $ | — |
| Three Months Ended March 31, 2019
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Non-guarantor Subsidiaries |  | Holdings |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 18.6 |  |  | $ | 89.6 |  |  | $ | 42.4 |  |  | $ | 9.3 |  |  | $ | — |  |  | $ | 159.9 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (6.8 | ) |  | (32.5 | ) |  | (29.4 | ) |  | (3.6 | ) |  | — |  |  | (72.3 | )
Acquisitions of businesses, net of cash acquired | — |  |  | — |  |  | — |  |  | (13.7 | ) |  | — |  |  | (13.7 | )
Funding of intercompany note receivable | (8.0 | ) |  | — |  |  | — |  |  | — |  |  | 8.0 |  |  | — |
Proceeds from repayment of intercompany note receivable | 5.0 |  |  | — |  |  | — |  |  | — |  |  | (5.0 | ) |  | — |
Other, net | (4.0 | ) |  | (0.1 | ) |  | (0.7 | ) |  | (0.7 | ) |  | — |  |  | (5.5 | )
Net cash used in investing activities | (13.8 | ) |  | (32.6 | ) |  | (30.1 | ) |  | (18.0 | ) |  | 3.0 |  |  | (91.5 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal borrowings on intercompany note payable | — |  |  | — |  |  | — |  |  | 8.0 |  |  | (8.0 | ) |  | — |
Principal payments on intercompany note payable | — |  |  | — |  |  | — |  |  | (5.0 | ) |  | 5.0 |  |  | — |
Borrowings on revolving credit facility | 25.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 25.0 |
Payments on revolving credit facility | (30.0 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (30.0 | )
Dividends paid on common stock | (28.2 | ) |  | — |  |  |  |  |  | (0.1 | ) |  | — |  |  | (28.3 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (19.5 | ) |  | — |  |  | — |  |  | (19.5 | )
Taxes paid on behalf of employees for shares withheld | (14.7 | ) |  | — |  |  | — |  |  | (1.2 | ) |  | — |  |  | (15.9 | )
Other, net | (14.7 | ) |  | (2.1 | ) |  | 5.6 |  |  | (1.8 | ) |  | — |  |  | (13.0 | )
Change in intercompany advances | 51.0 |  |  | (54.4 | ) |  | 2.1 |  |  | 1.3 |  |  | — |  |  | — |
Net cash used in financing activities | (11.6 | ) |  | (56.5 | ) |  | (11.8 | ) |  | 1.2 |  |  | (3.0 | ) |  | (81.7 | )
(Decrease) increase in cash, cash equivalents, and restricted cash | (6.8 | ) |  | 0.5 |  |  | 0.5 |  |  | (7.5 | ) |  | — |  |  | (13.3 | )
Cash, cash equivalents, and restricted cash at beginning of period | 41.5 |  |  | 3.0 |  |  | 69.4 |  |  | 19.6 |  |  | — |  |  | 133.5 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.7 |  |  | $ | 3.5 |  |  | $ | 69.9 |  |  | $ | 12.1 |  |  | $ | — |  |  | $ | 120.2 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 5.1 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 69.2 |
Restricted cash at beginning of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Long term restricted cash at beginning of period | — |  |  | — |  |  | 5.3 |  |  | — |  |  | — |  |  | 5.3 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 41.5 |  |  | $ | 3.0 |  |  | $ | 69.4 |  |  | $ | 19.6 |  |  | $ | — |  |  | $ | 133.5 |
Cash and cash equivalents at end of period | $ | 34.7 |  |  | $ | 3.5 |  |  | $ | 5.8 |  |  | $ | 12.1 |  |  | $ | — |  |  | $ | 56.1 |
Restricted cash at end of period | — |  |  | — |  |  | 59.0 |  |  | — |  |  | — |  |  | 59.0 |
Long term restricted cash at end of period | — |  |  | — |  |  | 5.1 |  |  | — |  |  | — |  |  | 5.1 |
Cash, cash equivalents, and restricted cash at end of period | $ | 34.7 |  |  | $ | 3.5 |  |  | $ | 69.9 |  |  | $ | 12.1 |  |  | $ | — |  |  | $ | 120.2 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration